Connect your AI

Revvity RVTY Diagnostics — Operating income (loss) from continuing operations

Discontinued — last reported Q3 '22

Similar metrics at other companies

DHRDiagnostics — Operating Income (Loss)

$674M-6.1%

LHDiagnostics — Operating Income

$458.7M+7.3%

TEC

TECHDiagnostics And Spatial Biology — Operating Income

$10.32M+22.5%

TMOSpecialty Diagnostics — Operating Income (Loss)

$313M+3.0%

ABTDiagnostic Products — Operating Earnings

$335M-6.7%

DGXDIS business — Operating Income (Loss)

$457M+10.4%

Other financials

Income statement

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

Market cap$11.16B-22.9%

Enterprise value$14.24B-13.7%

P/E46.5×-4.0×

P/S3.8×-1.4×

Profitability

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Revvity’s 10-Q, filed November 14, 2022, on SEC EDGAR. View the filing →

Ask your AI about Revvity's diagnostics — operating income (loss) from continuing operations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Revvity's diagnostics — operating income (loss) from continuing operations?: Revvity (RVTY) reported diagnostics — operating income (loss) from continuing operations of $94.65M in Q3 2022.
How has Revvity's diagnostics — operating income (loss) from continuing operations changed year-over-year?: Revvity's diagnostics — operating income (loss) from continuing operations decreased by 60.2% year-over-year, from $237.9M to $94.65M.
What does diagnostics — operating income (loss) from continuing operations mean?: The profit or loss generated by the Diagnostics segment after deducting operating expenses from segment revenue. This is the primary measure of the segment's core operational performance and profitability.